UA64009C2 - Pharmaceutical composition comprising antifungal agent and method for its production - Google Patents

Pharmaceutical composition comprising antifungal agent and method for its production Download PDF

Info

Publication number
UA64009C2
UA64009C2 UA2001021260A UA2001021260A UA64009C2 UA 64009 C2 UA64009 C2 UA 64009C2 UA 2001021260 A UA2001021260 A UA 2001021260A UA 2001021260 A UA2001021260 A UA 2001021260A UA 64009 C2 UA64009 C2 UA 64009C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
hydrophilic polymer
coating
oral pharmaceutical
inert core
Prior art date
Application number
UA2001021260A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Liconsa Liberation Controlada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA64009(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberation Controlada filed Critical Liconsa Liberation Controlada
Publication of UA64009C2 publication Critical patent/UA64009C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
UA2001021260A 1998-07-21 1999-07-20 Pharmaceutical composition comprising antifungal agent and method for its production UA64009C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
UA64009C2 true UA64009C2 (en) 2004-02-16

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001021260A UA64009C2 (en) 1998-07-21 1999-07-20 Pharmaceutical composition comprising antifungal agent and method for its production

Country Status (30)

Country Link
US (1) US6737082B1 (de)
EP (1) EP1103252B1 (de)
JP (1) JP4190732B2 (de)
KR (1) KR100572135B1 (de)
AT (1) ATE234077T1 (de)
AU (1) AU750730B2 (de)
BG (1) BG65187B1 (de)
BR (1) BR9912300A (de)
CA (1) CA2337509C (de)
CZ (1) CZ291938B6 (de)
DE (1) DE69905905T2 (de)
DK (1) DK1103252T3 (de)
EE (1) EE04415B1 (de)
ES (2) ES2157731B1 (de)
HR (1) HRP20010128B1 (de)
HU (1) HU228895B1 (de)
IL (1) IL140910A (de)
ME (1) MEP26708A (de)
MX (1) MXPA01000681A (de)
NO (1) NO320054B1 (de)
NZ (1) NZ509886A (de)
PL (1) PL194740B1 (de)
PT (1) PT1103252E (de)
RS (1) RS50063B (de)
RU (1) RU2209628C2 (de)
SK (1) SK283279B6 (de)
TR (1) TR200100177T2 (de)
UA (1) UA64009C2 (de)
WO (1) WO2000004881A1 (de)
ZA (1) ZA200101293B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE262799T1 (de) * 1996-01-31 2004-04-15 Univ South Alabama Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
YU43702A (sh) 1999-12-23 2004-11-25 Pfizer Products Inc. Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
EP1648467B1 (de) 2003-07-17 2018-03-21 Janssen Sciences Ireland UC Verfahren zur herstellung von ein antivirales mittel enthaltenden teilchen
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
AU2006283040B2 (en) 2005-08-22 2011-08-25 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011107466A2 (de) * 2010-03-05 2011-09-09 Basf Se Schmelzüberzogene arzneiformen
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
CA2987177A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once-daily oral pharmaceutical composition of isotretinoin
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3033065A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
EP3824296B1 (de) 2018-07-20 2026-04-01 Lipocine Inc. Orale pharmazeutische zusammensetzung mit testosterontridecanoat und/oder testosterondodecanoat zur behandlung von lebererkrankungen
CN118695852A (zh) * 2021-12-22 2024-09-24 帕劳制药有限公司 多颗粒阿巴康唑组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US6509038B2 (en) * 1996-05-20 2003-01-21 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
ID16956A (id) * 1996-05-24 1997-11-27 Schering Corp Komposisi antijamur dengan ketersediaan hayati yang tertingkatkan
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
CZ295502B6 (cs) * 1997-03-26 2005-08-17 Janssen Pharmaceutica N. V. Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet

Also Published As

Publication number Publication date
PT1103252E (pt) 2003-07-31
HU228895B1 (en) 2013-06-28
HK1037531A1 (en) 2002-02-15
YU3901A (sh) 2003-08-29
ES2157731B1 (es) 2002-05-01
CA2337509C (en) 2005-12-27
JP4190732B2 (ja) 2008-12-03
HUP0103708A2 (hu) 2002-02-28
EP1103252B1 (de) 2003-03-12
JP2002521323A (ja) 2002-07-16
TR200100177T2 (tr) 2001-07-23
IL140910A0 (en) 2002-02-10
EE200100041A (et) 2002-06-17
BR9912300A (pt) 2001-04-17
EE04415B1 (et) 2005-02-15
ES2157731A1 (es) 2001-08-16
ZA200101293B (en) 2001-08-21
EP1103252A1 (de) 2001-05-30
US6737082B1 (en) 2004-05-18
DE69905905T2 (de) 2004-03-04
SK862001A3 (en) 2001-08-06
CZ2001175A3 (en) 2001-05-16
NO320054B1 (no) 2005-10-17
IL140910A (en) 2004-03-28
PL194740B1 (pl) 2007-06-29
MXPA01000681A (es) 2002-04-24
WO2000004881A1 (es) 2000-02-03
DE69905905D1 (de) 2003-04-17
HUP0103708A3 (en) 2002-07-29
AU4782199A (en) 2000-02-14
HRP20010128B1 (en) 2003-12-31
HRP20010128A2 (en) 2002-12-31
PL345625A1 (en) 2002-01-02
RS50063B (sr) 2009-01-22
KR100572135B1 (ko) 2006-04-19
CZ291938B6 (cs) 2003-06-18
CA2337509A1 (en) 2000-02-03
NZ509886A (en) 2002-09-27
ATE234077T1 (de) 2003-03-15
DK1103252T3 (da) 2003-07-14
MEP26708A (en) 2010-06-10
RU2209628C2 (ru) 2003-08-10
ES2194480T3 (es) 2003-11-16
NO20010289D0 (no) 2001-01-17
BG65187B1 (bg) 2007-06-29
KR20010070990A (ko) 2001-07-28
NO20010289L (no) 2001-03-07
BG105282A (en) 2001-11-30
SK283279B6 (sk) 2003-05-02
AU750730B2 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
RU2209628C2 (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
KR0151893B1 (ko) 항진균제 및 폴리머로 코팅된 코아를 갖는 비드
CN100531724C (zh) 双相释放药理活性物质或其它物质的薄膜形制剂
CA2307037C (en) Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
TWI394595B (zh) Enteric granules and methods for their manufacture
HU227971B1 (en) Tramadol multiple unit formulations and process for producing them
JP2003533470A (ja) 経口投薬形態における、毒性コアの非毒性領域中へのカプセル化
AU729038B2 (en) Benzimidazole pharmaceutical composition and process of preparation
JP2813809B2 (ja) 有核顆粒製剤およびその製造法
KR100605235B1 (ko) 판토프라졸 함유 경질 캡슐 제제 및 그 제조방법
HK1037531B (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method